Furthermore, A study showed that epidermal growth factor (EGF) can stabilize PD-L1 expression and an EGF inhibitor (gefitinib) might enhance anti-tumor immunity in syngeneic mouse models [38]. This evidence concerns the gene EGF and neoplasm.